A single-dose, randomized crossover study in healthy chinese subjects to evaluate pharmacokinetics and bioequivalence of two capsules of calcium dobesilate 0.5 g under fasting and fed conditions

HIGHLIGHTS

• who: Yanmei Liu and colleagues from the Central Laboratory, Shanghai Xuhui Central Hospital, Shanghai, China, Shanghai Engineering Research have published the Article: A single-dose, randomized crossover study in healthy Chinese subjects to evaluate pharmacokinetics and bioequivalence of two capsules of calcium dobesilate 0.5 g under fasting and fed conditions, in the Journal: PLOS ONE of 22/03/2022
• what: This study was conducted to compare the bioequivalence of two products of calcium dobesilate capsules, which were assessed by conducting an open-label, randomized, single-dose, 2-period crossover bioequivalence study in healthy Chinese . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.